Drug Database
Back to search

France· FR:61402622

WINREVAIR 60 mg, poudre et solvant pour solution injectable

A sotatercept product containing sotatercept, registered in France by MERCK SHARP & DOHME (PAYS-BAS), on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC C02KX06

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedWINREVAIR 60 mg, poudre et solvant po…ATCC02KX06REGISTER NO.FR:61402622PACKS LISTED2CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about sotaterceptAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Sotatercept is registered in 11 of 19 countries.

Countries holding a registration under ATC C02KX06 (sotatercept), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 5 of them publish a price we can compare per daily dose
Search sotatercept products by name

Sotatercept · ATC C02KX06

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of sotatercept costs, country by country.

Normalised to the WHO defined daily dose (1 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Sotatercept · price per daily dose (1 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$167.27
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
SOTATERCEPT
Manufacturer
MERCK SHARP & DOHME (PAYS-BAS)
Country
France (FR)
ATC code
C02KX06
ATC class
Sotatercept
Defined daily dose
1 mg, P
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

2 priced
  • cip13
    3400930298558
    1 flacon en verre de 60 mg + 1 seringue préremplie en verre de 1,3 mL + 1 dispositif de transfert + 1 seringue doseuse + 1 aiguille + 4 lingettes alcoolisées
    EUR 8.84
  • cip13
    3400930298565
    2 flacons en verre de 60 mg + 2 seringues préremplies en verre de 1,3 mL + 2 dispositif de transfert + 1 seringue doseuse + 1 aiguille + 8 lingettes alcoolisées
    EUR 17.54

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

121 interactions on record for sotatercept.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check sotatercept against other medicinesHow interaction checks work

Sotatercept · interactions on record

121 records

121 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Sotatercept in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sotatercept products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Winrevair
  • Liechtenstein · Winrevair
  • Norway · Winrevair

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cebcef1b-067a-43fb-a206-f478aef76dcd
GET /v1/drugs/cebcef1b-067a-43fb-a206-f478aef76dcd?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "61402622",
  "date_amm": "2024-08-22",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/24/1850",
  "substance": "SOTATERCEPT",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "poudre et  solvant pour solution injectable",
  "voies_administration": "sous-cutanée",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Oui"
}
API referenceMCP serverPlans

See everything about sotatercept.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console